BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2688718)

  • 1. Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variables.
    Paganini EP; Abdulhadi MH; Garcia J; Magnusson MO
    ASAIO Trans; 1989; 35(3):513-5. PubMed ID: 2688718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation: results in hemodialysis patients previously treated with recombinant human erythropoietin.
    Paganini EP; Braun WE; Latham D; Abdulhadi MH
    ASAIO Trans; 1989; 35(3):535-8. PubMed ID: 2688720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correction of anemia in chronic kidney failure with lyophilized recombinant human erythropoietin using a subcutaneous approach].
    Amar M; Cendoroglo Neto M; Canziani ME; Nadaletto MA; Ajzen H; Draibe SA
    Rev Assoc Med Bras (1992); 1994; 40(2):101-7. PubMed ID: 7820145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are high flux dialysis and erythropoietin treatment in a collision course?
    Acchiardo SR; Quinn BP; Burk LB; Moore LW
    ASAIO Trans; 1989; 35(3):308-10. PubMed ID: 2688711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergometric results of r-erythropoietin treatment of hemodialysis patients].
    Hortian B; Schmidt R; Wüstenberg PW; Dörp E; Schumann L; Winkler R; Klinkmann H
    Z Gesamte Inn Med; 1990 May; 45(10):274-7. PubMed ID: 2392856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of using recombinant human erythropoietin on the effectiveness of hemodialysis in children with terminal renal failure].
    Pietrzyk JA; Dyras P; Smolnik T; Szymowska M
    Przegl Lek; 1992; 49(1-2):61-5. PubMed ID: 1280842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of erythropoietin therapy on diet and dialysis clearances in hemodialysis patients.
    Kaupke CJ; Vaziri ND; Sampson JR; Atkins K
    Int J Artif Organs; 1990 Apr; 13(4):218-22. PubMed ID: 2373550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of low dose erythropoietin: a possible advantage of high flux hemodialysis.
    Depner TA; Rizwan S; James LA
    ASAIO Trans; 1990; 36(3):M223-5. PubMed ID: 2252662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and clinical effect of recombinant human erythropoietin on the anemia of predialysis patients].
    Yamazaki C; Itoh A; Yamamoto N; Kobayashi M; Watanabe Y; Sakamoto N
    Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):701-10. PubMed ID: 1479710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.